Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT01579409
Other study ID # C11-20
Secondary ID 2011-A01003-38
Status Enrolling by invitation
Phase Phase 4
First received April 6, 2012
Last updated April 16, 2012
Start date November 2011
Est. completion date December 2013

Study information

Verified date April 2012
Source Institut National de la Santé Et de la Recherche Médicale, France
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Interventional

Clinical Trial Summary

In France, primary cardiovascular and metabolic prevention is supported by the French National Program for Nutrition and Health (PNNS: Programme National Nutrition Santé).

The investigators made the hypothesis that, independently of other diseases, the non adherence in PNNS guidelines would lead to arterial stiffness, endothelial dysfunction, change in microcirculation and in cardiac autonomic system. These changes may exist at fasting but also be reinforced after a standardised breakfast.

The investigators aim is to evaluate arterial stiffness, endothelial function, microcirculation and cardiac autonomic system according to PNNS status in a case control study.


Description:

This is a case / control pilot nested in SU.VI.MAX 2 (SUpplémentation en VItamines et Minéraux Anti-oXydants) study. The randomized longitudinal placebo controlled SU.VI.MAX study tested the preventive effect of vitamin and antioxidant minerals supplementation on the incidence and the mortality from cardiovascular pathologies and cancers. SU.VI.MAX 2 was the extension of the previous study and included 7200 subjects for whom food habits were known and characterized according to PNNS guidelines (PNNS score).

The subjects will be pre-selected from the original cohort SU.VI.MAX2 if they have a PNNS score in 2007 in the 1-40th or 60-100th percentiles of distribution. If they accept to participate, a new PNNS score will be calculated in 2012-2013 and the subjects in the 1-25th or 75-100th percentiles will be included and explored during one day of participation.

Our aim is to evaluate arterial stiffness, endothelial function, microcirculation and cardiac autonomic system according to PNNS status in a case control study.

Our secondary objective is to evaluate the same parameters in the same subjects but after a breakfast containing 75 g glucose.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 94
Est. completion date December 2013
Est. primary completion date August 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 50 Years to 75 Years
Eligibility Inclusion Criteria:

- Social Security affiliation.

- Participation in SU.VI.MAX 2.

- Subjects without legal guardian who can freely agree to participate to the study.

- PNNS score in 2012 lower (cases) or upper (controls) quartile.

Exclusion Criteria:

- Known diabetes or prediabetes before the inclusion.

- History of cardiovascular disease.

- Treatment for hypertension.

- Treatment for dyslipidemia.

- Known Cancer

- Smoking or patients that have stopped smoking less than 3 years

- Cardiac pacemaker

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening


Related Conditions & MeSH terms

  • French PNNS Guidelines in Vascular Function

Intervention

Other:
PNNS guidelines
Application of PNNS guidelines

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Institut National de la Santé Et de la Recherche Médicale, France

Outcome

Type Measure Description Time frame Safety issue
Primary Pulse Wave Velocity This is a pilot study. Pulse wave velocity, an index of arterial stiffness, was chosen as the primary endpoint. A total of 47 subjects in each group was necessary to detect a difference between groups of 1m/s in pulse wave velocity (standard deviation of 1.7 m/s) with a statistical power of 80%, at fasting. During the fasting state, within the hour preceding the standardised breakfast that provides 75 gr of carbohydrates No
Primary Peripheral arterial augmentation index (Aix ) During the fasting state, within the hour preceding the standardised breakfast that provides 75 gr of carbohydrates No
Primary High and low frequency peaks in heart variability spectral analysis During the fasting state, within the hour preceding the standardised breakfast that provides 75 gr of carbohydrates No
Primary High and low frequency peaks in systolic and diastolic blood pressure spectral analysis During the fasting state, within the hour preceding the standardised breakfast that provides 75 gr of carbohydrates No
Primary Mean cutaneous blood flow measured by laser doppler flowmetry During the fasting state, within the hour preceding the standardised breakfast that provides 75 gr of carbohydrates No
Primary Mean cutaneous blood flow measured by laser doppler flowmetry, spectral analysis During the fasting state, within the hour preceding the standardised breakfast that provides 75 gr of carbohydrates No
Primary Percentage of variation of cutaneous blood flow laser doppler measurements after paced breathing (6/min) During the fasting state, within the hour preceding the standardised breakfast that provides 75 gr of carbohydrates No
Primary Increase in cutaneous blood flow laser doppler measurements after acetylcholine iontophoresis During the fasting state, within the hour preceding the standardised breakfast that provides 75 gr of carbohydrates No
Primary Reactive Hyperemia Index after branchial artery occlusion During the fasting state, within the hour preceding the standardised breakfast that provides 75 gr of carbohydrates No
Primary Aortic , radial,digital artery, systolic, diastolic and pulsatile pressures During the fasting state, within the hour preceding the standardised breakfast that provides 75 gr of carbohydrates No
Secondary Comparison of the above mentioned parameters after a standardised breakfast After the standardised breakfast that provides 75 gr of carbohydrates, hourly for the next 3 hours following the end of the standardised breakfast No